Epigenetic clocks measure biological age consistently in the laboratory but fluctuate significantly in response to daily physiological events, undermining their clinical utility. This technical-biological gap means most current clocks cannot reliably predict health outcomes or track intervention effects in real-world conditions.
Key Points
- Most epigenetic clocks show excellent technical reproducibility but poor biological stability
- Daily meals, stress, and environmental exposures cause substantial clock variability in individuals
- Technical reliability does not predict biological reliability or clinical prediction accuracy
Longevity Analysis
Epigenetic clocks have promised objective measurement of aging rate and personalized risk assessment, but this research exposes a fundamental problem: laboratory consistency means little if the biomarker shifts with ordinary physiological events. This distinction between what can be measured precisely and what actually reflects the aging process itself has immediate consequences for clinical decision-making. Any intervention trial relying on these clocks as primary endpoints may produce misleading results if daily noise drowns out true biological change. Practitioners considering epigenetic clocks for patient monitoring or intervention tracking should recognize that current versions cannot reliably distinguish genuine aging acceleration from transient responses to meals, stress, or environmental factors. This work redirects attention to the biological signal underneath the measurement—understanding what actually drives aging rate, rather than refining an instrument that captures noise
Original published by Wiley Aging Cell, by Raghav Sehgal, Daniel S. Borrus, John Gonzalez, Yaroslav Markov, Albert Higgins‐Chen, Alzheimer's Disease Neuroimaging Initiative .